Cited by 191Smoking Behavior and CessationLiver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

The DOI matches its Crossref record; 145 of the 147 references it cites were found in a registry or an index.

Cigarette smoking and liver diseases

Open access

Marti-Aguado, David, Clemente-Sanchez, Ana, Bataller, Ramon·2022·Journal of Hepatology

DOI 10.1016/j.jhep.2022.01.016

Open this paper in CoChat — free account Open PDF

Abstract

Cigarette smoking is a preventable risk factor for premature morbidity and mortality. A history of smoking is observed in approximately 40% of patients with liver disease, while a growing number of studies are investigating the potential impact of smoking in chronic liver diseases. This review discusses the effects of smoking on liver diseases, at multiple levels, with a focus on its potential causal role. Clinical evidence indicates that cigarette smoking negatively impacts the incidence and severity of fatty liver disease, fibrosis progression, hepatocellular carcinoma development, and the outcomes of patients with advanced liver disease. The underlying mechanisms are complex and involve different pathophysiological pathways including oxidative stress and oncogenic signals. Importantly, smoking promotes cardiovascular disease and extrahepatic cancers in patients with steatohepatitis and in transplant recipients. We discuss how promoting smoking cessation could improve the rates of treatment response (in clinical trials) and fibrosis regression, while reducing the risk of hepatocellular carcinoma and improving liver transplant outcomes. Finally, we discuss current challenges such as the referral of smokers to specialised units for smoking cessation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2022.01.016

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Liver fibrosis
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Self-citation
NAFLD: A multisystem disease
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,144
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
Reitsma, M. B., Fullman, N., Ng, M., Salama, J. S., Abajobir, A., Abate, K. H., Abbafati, C., Abera, S. F., Abraham, B., Abyu, G. Y., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30819-x · Cited by 2,028
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,429
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,224
Consequences of smoking for body weight, body fat distribution, and insulin resistance
Chiolero, A., Faeh, D., Paccaud, F., & Cornuz, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.801 · Cited by 1,192
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Taylor, R. S., Taylor, R. J., Bayliss, S., Hagström, H., Nasr, P., Schattenberg, J. M., Ishigami, M., Toyoda, H., Wai-Sun Wong, V., Peleg, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.043 · Cited by 1,069
Effects of tobacco smoke on immunity, inflammation and autoimmunity
Arnson, Y., Shoenfeld, Y., & Amital, H. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.003 · Cited by 966
Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study
Vilar-Gomez, E., Calzadilla-Bertot, L., Wai-Sun Wong, V., Castellanos, M., Aller-de la Fuente, R., Metwally, M., Eslam, M., Gonzalez-Fabian, L., Alvarez-Quiñones Sanz, M., Conde-Martin, A. F., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.034 · Cited by 806
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766
Insulin resistance and cigarette smoking
Facchini, F. S., Hollenbeck, C. B., Jeppesen, J., Chen, Y. I., & Reaven, G. M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90730-q · Cited by 723
Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
Pimpin, L., Cortez‐Pinto, H., Negro, F., Corbould, E., Lazarus, J. V., Webber, L., & Sheron, N. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.011 · Cited by 720
Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?
Qiu, F., Liang, C.-L., Liu, H., Zeng, Y., Hou, S., Huang, S. M., Lai, X., & Dai, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.13613 · Cited by 628
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview‐based study of 1032 patients
Gershwin, E. M., Selmi, C., Worman, H. J., Gold, E. B., Watnik, M., Utts, J., Lindor, K. D., Kaplan, M. M., & Vierling, J. M. (2005) · Hepatology · doi:10.1002/hep.20907 · Cited by 621
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia
Crabb, D. W., Bataller, R. A., Chalasani, N., Kamath, P. S., Lucey, M. R., Mathurin, P., McClain, C. J., McCullough, A. J., Mitchell, M. C., Morgan, T. R. M., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.042 · Cited by 554
Self-citation
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
Chan, A. W. H., Zhong, J., Berhane, S., Toyoda, H., Cucchetti, A., Shi, K., Tada, T., Chong, C. C. N., Xiang, B., Li, L., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.027 · Cited by 551
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China
Xu, X.-F., Xing, H., Han, J., Li, Z.-L., Lau, W.-Y., Zhou, Y.-H., Gu, W.-M., Wang, H., Chen, T.-H., Zeng, Y.-Y., et al. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2018.4334 · Cited by 532
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
Marrero, J. A., Fontana, R. J., Fu, S., Conjeevaram, H. S., Su, G. L., & Lok, A. S.-F. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.005 · Cited by 515
Electronic Cigarettes and Conventional Cigarette Use Among US Adolescents: A Cross-sectional Study
Dutra, L. M., & Glantz, S. A. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.5488 · Cited by 496
Cigarette smoke induces proinflammatory cytokine release by activation of NF-κB and posttranslational modifications of histone deacetylase in macrophages
Yang, S., Chida, A. S., Bauter, M. R., Shafiq, N., Seweryniak, K. E., Maggirwar, S. B., Kilty, I., & Rahman, I. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00241.2005 · Cited by 488
Autoimmune hepatitis
Mieli‐Vergani, G., Vergani, D., Czaja, A. J., Manns, M. P., Krawitt, E. L., Vierling, J. M., Lohse, A. W., & Montaño‐Loza, A. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.17 · Cited by 485
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis
Corpechot, C., Barbu, V., Wendum, D., Kinnman, N., Rey, C., Poupon, R. Y., Housset, C., & Rosmorduc, O. (2002) · Hepatology · doi:10.1053/jhep.2002.32524 · Cited by 483
Microsomal Ethanol‐Oxidizing System (MEOS): The First 30 Years (1968‐1998)–A Review
Lieber, C. S. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04217.x · Cited by 426
Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes
Münzel, T. F., Hahad, O., Kuntić, M., Keaney, J. F., Deanfield, J. E., & Daiber, A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa460 · Cited by 418
Role of free radicals in liver diseases
Muriel, P. (2009) · Hepatology International · doi:10.1007/s12072-009-9158-6 · Cited by 380
Association of histologic disease activity with progression of nonalcoholic fatty liver disease
Kleiner, D. E., Brunt, E. M., Wilson, L. A., Behling, C., Guy, C., Contos, M., Cummings, O., Yeh, M., Gill, R., Chalasani, N., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.12565 · Cited by 372
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review
Loomba, R. S., Lim, J. K., Patton, H. M., & El‐Serag, H. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.053 · Cited by 360
Cigarette Smoke Silences Innate Lymphoid Cell Function and Facilitates an Exacerbated Type I Interleukin-33-Dependent Response to Infection
Kearley, J., Silver, J. S., Sandén, C., Liu, Z., Berlin, A. A., White, N. M., Mori, M., Pham, T., Ward, C. K., Criner, G. J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.011 · Cited by 358
Active Smoking and Risk of Metabolic Syndrome: A Meta-Analysis of Prospective Studies
Sun, K., Liu, J., & Ning, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047791 · Cited by 337
Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directions
Iwakiri, Y., Shah, V. H., & Rockey, D. C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.047 · Cited by 323
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
Fouts, D. E., Torralba, M., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.019 · Cited by 311
Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers
Yu, M., Hsu, F.-C., Sheen, I. S., Chu, C., Lin, D., Chen, C., & Liaw, Y. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009060 · Cited by 289
The Renormalization of Smoking? E-Cigarettes and the Tobacco “Endgame”
Fairchild, A. L., Bayer, R., & Colgrove, J. K. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1313940 · Cited by 280
Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors
Baecker, A. S., Liu, X., Vecchia, C. L., & Zhang, Z. (2018) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000428 · Cited by 277
Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
Åberg, F., Helenius‐Hietala, J., Puukka, P., Färkkilä, M., & Jula, A. (2018) · Hepatology · doi:10.1002/hep.29631 · Cited by 267
Five‐year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence
Pessione, F., Mj, R., Peters, L., Pham, B., Batel, P., RUEFF, B., & Valla, D. C. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.01804.x · Cited by 261
Alcohol, Smoking, Cofee, and Cirrhosis
Klatsky, A. L., & Armstrong, M. A. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116433 · Cited by 257
Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the Liver Cancer Pooling Project
Petrick, J. L., Campbell, P. T., Koshiol, J., Thistle, J. E., Andreotti, G., Beane-Freeman, L. E., Buring, J. E., Chan, A. T., Chong, D. Q., Doody, M. M., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0007-z · Cited by 257
Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer
Lee, Y.-C. A., Cohet, C., Yang, Y.-C., Stayner, L. T., Hashibe, M., & Straíf, K. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp280 · Cited by 255
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Alexander, M., Loomis, A. K., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., Mosseveld, M., et al. (2019) · BMJ · doi:10.1136/bmj.l5367 · Cited by 254
Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects
Teschke, R. (2018) · Biomedicines · doi:10.3390/biomedicines6040106 · Cited by 244
Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain
Caballería, L., Pera, G., Auladell, M. A., Torán‐Monserrat, P., Muñoz, L., Miranda, D., Alumà, A., Casas, J. D., Sánchez, C., Gil, D., et al. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832fcdf0 · Cited by 239
Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease
Guo, B., Guo, Y., Nima, Q., Feng, Y., Wang, Z., Lu, R., Baimayangji, Ma, Y., Zhou, J., Xu, H. Y., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.016 · Cited by 238
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis
Corpechot, C., Chrétien, Y., Chazouillères, O., & Poupon, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.019 · Cited by 235
Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
Zein, C. O., Ünalp, A., Colvin, R., Liu, Y.-C., & McCullough, A. J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.040 · Cited by 226
Expression of MAGE-antigens in normal tissues and cancer
Jungbluth, A. A., BUSAM, K. J., Kolb, D., Iversen, K., Coplan, K. A., Chen, Y., Spagnoli, G. C., & Old, L. J. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4 · Cited by 214
Cigarette Smoking, Alcohol Drinking, Hepatitis B, and Risk for Hepatocellular Carcinoma in Korea
Jee, S. H., Ohrr, H., Sull, J. W., & Samet, J. M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh334 · Cited by 209
Association or causation: evaluating links between "environment and disease".
Lucas, R. M., & McMichael, A. J. (2005) · Europe PMC (PubMed Central) · Cited by 208
Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy
Geng, Y., Savage, S. M., Razani‐Boroujerdi, S., & Sopori, M. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2384 · Cited by 207
Cigarette Smoking and Hepatic Lesions in Patients With Chronic Hepatitis C
Pessione, F., Ramond, M.-J., Njapoum, C., Duchatelle, V., Degott, C., Erlinger, S., RUEFF, B., Valla, D. C., & Degos, F. (2001) · Hepatology · doi:10.1053/jhep.2001.25385 · Cited by 207
Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification
Ioannou, G. N., Green, P. K., Kerr, K. F., & Berry, K. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.008 · Cited by 191
Ageing, telomeres, senescence, and liver injury
Hoare, M., Das, T., & Alexander, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.009 · Cited by 184
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study
Abeysekera, K. W. M., Fernandes, G., Hammerton, G., Portal, A. J., Gordon, F. H., Heron, J., & Hickman, M. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30419-4 · Cited by 182
Adverse Effects of Cigarette Smoke on NO Bioavailability
Zhang, W., Venardos, K. M., Chin-Dusting, J. P. F., & Kaye, D. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000231509.27406.42 · Cited by 180
In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset
Harada, K., de Water, J. V., Leung, P. S. C., Coppel, R. L., Ansari, A. A., Nakanuma, Y., & Gershwin, M. E. (1997) · Hepatology · doi:10.1002/hep.510250402 · Cited by 165
Cancer and Smoking
Fisher, R. A. (1958) · Nature · doi:10.1038/182596a0 · Cited by 163
Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis
Ajmera, V. H., Belt, P. H., Wilson, L., Gill, R. M., Loomba, R. S., Kleiner, D. E., Neuschwander‐Tetri, B. A., & Terrault, N. A. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.026 · Cited by 157
Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation
Pungpapong, S., Manzarbeitia, C., Ortiz, J., Reich, D. J., Araya, V., Rothstein, K. D., & Muñoz, S. J. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.34150 · Cited by 155
Interaction between Cigarette Smoking and Hepatitis B and C Virus Infection on the Risk of Liver Cancer: A Meta-analysis
Chuang, S.-C., Lee, Y. A., Hashibe, M., Dai, M., Zheng, T., & Boffetta, P. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1297 · Cited by 149
Cigarette Smoking Exacerbates Nonalcoholic Fatty Liver Disease in Obese Rats
Azzalini, L., Ferrer, E., Ramalho, L. N. Z., Moreno, M., Domínguez, M., Colmenero, J., Peinado, V. I., Barberà, J. A., Arroyo, V., Ginès, P., et al. (2009) · Hepatology · doi:10.1002/hep.23516 · Cited by 148
Self-citation
Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study
Jung, H. S., Chang, Y., Kwon, M., Sung, E., Yun, K. E., Cho, Y. K., Shin, H. C., & Ryu, S. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0283-5 · Cited by 144
Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1
Yuan, H., Shyy, J. Y.-J., & Martins‐Green, M. M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.026 · Cited by 133
Active Smoking, Passive Smoking, and Risk of Nonalcoholic Fatty Liver Disease (NAFLD): A Population-Based Study in China
Liu, Y., Dai, M., Bi, Y., Xu, M., Xu, Y., Li, M., Wang, T., Huang, F., Xu, B., Zhang, J., et al. (2013) · Journal of Epidemiology · doi:10.2188/jea.je20120067 · Cited by 132
The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption
The Provincial Group for the Study of Chronic Liver Disease, Corrao, G., Lepore, A. R., Torchio, P., Valenti, M., GALATOLA, G., D’Amicis, A., Aricò, S., & di Orio, F. (1994) · European Journal of Epidemiology · doi:10.1007/bf01719277 · Cited by 132
Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study
Hajifathalian, K., Torabi Sagvand, B., & McCullough, A. J. (2019) · Hepatology · doi:10.1002/hep.30226 · Cited by 128
Impact of smoking on histological liver lesions in chronic hepatitis C
Hézode, C., Lonjon, I., Roudot‐Thoraval, F., Mavier, J.-P., Pawlotsky, J., Zafrani, E. S., & Dhumeaux, D. (2002) · Gut · doi:10.1136/gut.52.1.126 · Cited by 122
Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: an updated systematic review of 81 epidemiological studies
Abdel-Rahman, O., Helbling, D., Schöb, O., Eltobgy, M., Mohamed, H., Schmidt, J., giryes, A., Mehrabi, A., Iype, S., John, H., et al. (2017) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12270 · Cited by 118
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target
Ningarhari, M., Caruso, S., Hirsch, T. Z., Bayard, Q., Franconi, A., Védié, A., Noblet, B., Blanc, J., Amaddeo, G., Ganne‐Carrié, N., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.052 · Cited by 118
Polycyclic aromatic hydrocarbon‐DNA adducts in liver tissues of hepatocellular carcinoma patients and controls
Chen, S., Wang, L., Lunn, R. M., Tsai, W., Lee, P., Lee, C., Ahsan, H., Zhang, Y., Chen, C., & Santella, R. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10291 · Cited by 117
General mechanisms of nicotine‐induced fibrogenesis
Jensen, K. J., Nizamutdinov, D., Guerrier, M., Afroze, S. H., Dostal, D. E., & Glaser, S. S. (2012) · The FASEB Journal · doi:10.1096/fj.12-206458 · Cited by 115
Cardiovascular risk factors in non‐alcoholic fatty liver disease
Hagström, H., Nasr, P., Ekstedt, M., Hammar, U., Stal, P. I., Askling, J., Hultcrantz, R. W., & Kechagias, S. (2018) · Liver International · doi:10.1111/liv.13973 · Cited by 109
Smoking-related morbidity and mortality following liver transplantation
Leithead, J., Ferguson, J., & Hayes, P. C. (2008) · Liver Transplantation · doi:10.1002/lt.21471 · Cited by 105
Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment
Zein, C. O., Beatty, K., Post, A. B., Logan, L., Debanne, S. A., & McCullough, A. J. (2006) · Hepatology · doi:10.1002/hep.21423 · Cited by 104
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
Ampuero, J., Aller, R., Gallego‐Durán, R., Crespo, J., Calleja, J. L., García‐Monzón, C., Gómez‐Camarero, J., Caballería, J., Iacono, O. L., Ibáñez, L., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.028 · Cited by 103
Cigarette smoking and chronic liver diseases
Altamirano, J., & Bataller, R. A. (2010) · Gut · doi:10.1136/gut.2008.162453 · Cited by 98
Self-citation
Smoking and risk of liver cirrhosis: a population-based cohort study
Dam, M. K., Flensborg‐Madsen, T., Eliasen, M., Becker, U., & Tolstrup, J. S. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.777469 · Cited by 98
Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice
Zuo, L., Li, Y., Wang, H., Wu, R., Zhu, W., Zhang, W., Cao, L., Gu, L., Gong, J., Li, N., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.08.008 · Cited by 94
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis
Younossi, Z. M., Stepanova, M., Anstee, Q. M., Lawitz, E., Wong, V. W., Romero‐Gómez, M., Kersey, K., Li, G., Subramanian, G. M., Myers, R. P., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.02.024 · Cited by 87
Liver Transplantation for Alcoholic Liver Disease
Addolorato, G., Bataller, R. A., Burra, P., DiMartini, A., Graziadei, I. W., Lucey, M. R., Mathurin, P., O’Grady, J., Pageaux, G., & Berenguer, M. (2016) · Transplantation · doi:10.1097/tp.0000000000001156 · Cited by 83
Self-citation
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals
Bazerbachi, F., Haffar, S., Wang, Z., Cabezas, J., Arias, M., Crespo, J., Murad, S. D., Ikram, M. A., Olynyk, J. K., Gan, E. K., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.069 · Cited by 82
Invalidity of an Oft-Cited Estimate of the Relative Harms of Electronic Cigarettes
Eissenberg, T., Bhatnagar, A., Chapman, S., Jordt, S., Shihadeh, A., & Soule, E. K. (2020) · American Journal of Public Health · doi:10.2105/ajph.2019.305424 · Cited by 79
Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells
Soeda, J., Morgan, M. L., McKee, C. M., Mouralidarane, A., Lin, C., Roskams, T., & Oben, J. A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.151 · Cited by 78
Co-occurring risk factors for alcohol dependence and habitual smoking: update on findings from the Collaborative Study on the Genetics of Alcoholism.
Grucza, R. A., & Bierut, L. J. (2006) · PubMed Central · Cited by 77
Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis
Corpechot, C., Gaouar, F., Chrétien, Y., Johanet, C., Chazouillères, O., & Poupon, R. Y. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.031 · Cited by 75
Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
Björkström, K., Franzén, S., Eliasson, B., Miftaraj, M., Guðbjörnsdóttir, S., Lagerros, Y. T., Svensson, A., & Hagström, H. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.038 · Cited by 75
Relationship of Smoking and Fibrosis in Patients With Chronic Hepatitis C
Dev, A. T., Patel, K., Conrad, A. J., Blatt, L. M., & McHutchison, J. G. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.019 · Cited by 72
Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study
Okamoto, M., Miyake, T., Kitai, K., Furukawa, S., Yamamoto, S., Senba, H., Kanzaki, S., Deguchi, A., Koizumi, M., Ishihara, T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195147 · Cited by 68
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
Shih, W., Chang, H., Liaw, Y., Lin, S., Lee, S., Chen, P., Liu, C., Lin, C., & Yu, M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27508 · Cited by 65
Dangers of Cigarette-smoking
Fisher, R. A. (1957) · BMJ · doi:10.1136/bmj.2.5039.297-b · Cited by 63
Additive Effects of Nicotine and High-Fat Diet on Hepatic Steatosis in Male Mice
Friedman, T. C., Sinha‐Hikim, I., Parveen, M., Najjar, S. M., Liu, Y., Mangubat, M., Shin, C., Lyzlov, A., Ivey, R., Shaheen, M. A., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1750 · Cited by 59
Cigarette Smoking and Liver Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence among Japanese
Tanaka, K., Tsuji, I., Wakai, K., Nagata, C., Mizoue, T., Inoue, M., & Tsugane, S. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl040 · Cited by 55
Cigarette smoking exposure breaks the homeostasis of cholesterol and bile acid metabolism and induces gut microbiota dysbiosis in mice with different diets
Yang, Y., Yang, C., Lei, Z., Rong, H., Yu, S., Wu, H., Yang, L., Lei, Y., Liu, W., Nie, Y., et al. (2021) · Toxicology · doi:10.1016/j.tox.2021.152678 · Cited by 55
Incidence and risk factors for the development of lung tumors after liver transplantation
Jiménez, C., Manrique, A., Marqués, E., Ortegz, P., Loinaz, C., Gómez, R., Meneu, J. C., Abradelo, M., Elola-Olaso, A. M., López, A. C., et al. (2006) · Transplant International · doi:10.1111/j.1432-2277.2006.00397.x · Cited by 53
E‐cigarettes and Western Diet: Important Metabolic Risk Factors for Hepatic Diseases
Hasan, K. M., Friedman, T. C., Shao, X. M., Parveen, M., Sims, C., Lee, D. L., Espinoza‐Derout, J., Sinha‐Hikim, I., & Sinha‐Hikim, A. P. (2019) · Hepatology · doi:10.1002/hep.30512 · Cited by 53
The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude
Webb, G. J., Ryan, R. P., Marshall, T. P., & Hirschfield, G. M. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.01.029 · Cited by 53
Association between cotinine‐verified smoking status and risk of nonalcoholic fatty liver disease
Kim, N. H., Jung, Y. S., Hong, H. P., Park, J. H., Kim, H. J., Park, D. I., Cho, Y. K., Sohn, C. I., Jeon, W. K., & Kim, B. I. (2018) · Liver International · doi:10.1111/liv.13701 · Cited by 52
Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
Ou, H., Fu, Y., Liao, W., Zheng, C., & Wu, X. (2019) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2019/6028952 · Cited by 50
Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B
Hodge, A. D., Lim, S., Goh, E., Wong, O., Marsh, P. J., Knight, V., Sievert, W., & de Courten, B. V. (2017) · Nutrients · doi:10.3390/nu9010056 · Cited by 49
The Effect of Nicotine and Its Interaction with Carbon Tetrachloride in the Rat Liver
Yuen, S. T., Gogo, A. R., Luk, I. S. C., Cho, C. H., Ho, J. C. I., & Loh, T. T. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb01017.x · Cited by 48
Hepatic DNA Damage Induced by Electronic Cigarette Exposure Is Associated With the Modulation of NAD+/PARP1/SIRT1 Axis
Espinoza‐Derout, J., Shao, X. M., Bankole, E., Hasan, K. M., Mtume, N., Liu, Y., Sinha‐Hikim, A. P., & Friedman, T. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00320 · Cited by 47
Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase
Wang, Y., Chuang, Y., Wu, C., Jan, M., Wu, W., Lin, C., Liu, C., Yang, Y., Chen, P., Lin, S., et al. (2018) · Hepatology · doi:10.1002/hep.30339 · Cited by 46
E-Cigarette Flavoring Chemicals Induce Cytotoxicity in HepG2 Cells
Rickard, B. P., Ho, H. S. S., Tiley, J. B., Jaspers, I., & Brouwer, K. L. R. (2021) · ACS Omega · doi:10.1021/acsomega.0c05639 · Cited by 44
Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis
Gaspar, R., Rodrigues, S. G., Silva, M., Costa‐Moreira, P., Morais, R., Andrade, P., Cardoso, H., Albuquerque, A., Liberal, R., & Macedo, G. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.03.016 · Cited by 41
Questionnaire based assessment of risk factors for primary biliary cirrhosis
Lammert, C., Nguyen, D. L., Juran, B. D., Schlicht, E., Larson, J. J., Atkinson, E. J., & Lazaridis, K. N. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.01.028 · Cited by 40
Time to ban smoking in patients with chronic liver diseases
Bataller, R. A. (2006) · Hepatology · doi:10.1002/hep.21484 · Cited by 40
Self-citation
Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis
Yoshioka, N., Ishigami, M., Watanabe, Y., Sumi, H., Doisaki, M., Yamaguchi, T., Ito, T., Ishizu, Y., Kuzuya, T., Honda, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57369-9 · Cited by 40
Heavy cigarette smoking induces hypoxic polycythemia (erythrocytosis) and hyperuricemia in chronic hepatitis C patients with reversal of clinical symptoms and laboratory parameters with therapeutic phlebotomy
El‐Zayadi, A., Selim, O., Hamdy, H., El-Tawil, A., & Moustafa, H. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05718.x · Cited by 39
Effect of smoking on survival of patients with hepatocellular carcinoma
Kolly, P., Knöpfli, M., & Dufour, J. (2017) · Liver International · doi:10.1111/liv.13466 · Cited by 39
Cigarette Smoking Increased Risk of Overall Mortality in Patients With Non-alcoholic Fatty Liver Disease: A Nationwide Population-Based Cohort Study
Charatcharoenwitthaya, P., Karaketklang, K., & Aekplakorn, W. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.604919 · Cited by 39
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study
Rathi, S., Chopra, M., Chouduri, G., Sharma, P., Madan, K., Chhabra, M., Rai, R. R., Govil, A., Konar, A., Goenka, M. K., et al. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.09.009 · Cited by 38
Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B
Tsochatzis, E. A., Papatheodoridis, G., Manolakopoulos, S., TINIAKOS, D. G., Manesis, E. K., & Archimandritis, A. J. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520902803515 · Cited by 37
Differential carcinogenicity of cigarette smoke in mice exposed either transplacentally, early in life or in adulthood
Balansky, R. M., Ganchev, G., Iltcheva, M., Nikolov, M., Steele, V. E., & Flora, S. D. (2011) · International Journal of Cancer · doi:10.1002/ijc.26103 · Cited by 35
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
Savari, F., Mard, S. A., Badavi, M., Rezaie, A., & Gharib-Naseri, M. K. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1041-x · Cited by 35
Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway
Xie, C., Zhu, J., Wang, X., Chen, J., Geng, S., Wu, J., Zhong, C., & Li, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1052-z · Cited by 33
Stratification of patients in NASH clinical trials: A pitfall for trial success
Ampuero, J., & Romero‐Gómez, M. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100148 · Cited by 30
E-Cigarette Use: Device Market, Study Design, and Emerging Evidence of Biological Consequences
Snoderly, H. T., Nurkiewicz, T. R., Bowdridge, E. C., & Bennewitz, M. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212452 · Cited by 30
Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice
Sugamori, K. S., Brenneman, D., Sanchez, O. H., Doll, M. A., Hein, D. W., Pierce, W. M. J., & Grant, D. M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.12.022 · Cited by 29
Synergistic effect of fatty liver and smoking on metabolicsyndrome
Chiang, P.-H., Chang, T.-Y., & Chen, J. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5334 · Cited by 27
Interaction between interleukin-1β −31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese
Sakamoto, T., Higaki, Y., Hara, M., Ichiba, M., Horita, M., Mizuta, T., Eguchi, Y., Yasutake, T., Ozaki, I., Yamamoto, K., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.036 · Cited by 25
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum
Patel, Y. A., Imperial, J. C., Muir, A. J., Anstee, Q. M., DeBrota, D., Dimick-Santos, L., Filozof, C., Mehta, R., Sanyal, A. J., Schabel, E., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.024 · Cited by 25
Association of smoking with liver fibrosis and mortality in primary biliary cholangitis
Μantaka, A., Koulentaki, M., Samonakis, D. N., Sifaki-Pistolla, D. I., Voumvouraki, A., Tzardi, M. N., & Kouroumalis, E. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001234 · Cited by 25
Synergistic and Non-synergistic Associations for Cigarette Smoking and Non-tobacco Risk Factors for Cardiovascular Disease Incidence in the Atherosclerosis Risk In Communities (ARIC) Study
Lubin, J. H., Couper, D. J., Lutsey, P. L., & Yatsuya, H. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw235 · Cited by 22
Management of Lifestyle Factors in Individuals with Cirrhosis: A Pragmatic Review
Tandon, P., & Berzigotti, A. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1696639 · Cited by 22
Mainstream cigarette smoke accelerates the progression of nonalcoholic steatohepatitis by modulating Kupffer cell-mediated hepatocellular apoptosis in adolescent mice
Park, S., Kim, J., Yun, H., Choi, S., Lee, S. H., Choi, K., Lim, C. W., Lee, K., & Kim, B. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.05.012 · Cited by 20
Caracterización de los tumores malignos de novo en el trasplante hepático
Catalina-Rodríguez, M. V., de Diego, A., García, Á. S., Escudero, M., Salcedo, M. M., Bañares, R., & Clemente, G. (2003) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(03)79044-x · Cited by 19
Smoking is associated with severity of liver fibrosis but not with histological severity in nonalcoholic fatty liver disease. Results from a cross-sectional study
Munsterman, I. D., Smits, M. M., Andriessen, R., van Nieuwkerk, C. M. J., Bloemena, E., Mulder, C. J. J., Tjwa, E. T. T. L., & van Geenen, E. J. M. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1315169 · Cited by 19
Impacts of cigarette smoking on liver fibrosis and its regression under therapy in male patients with chronic hepatitis B
Xiong, M., Li, J., Yang, S., Zeng, F., Ji, Y., Liu, J., Wu, Q., He, Q., Tang, X., Jiang, R., et al. (2019) · Liver International · doi:10.1111/liv.14108 · Cited by 19
Secondhand Smoke Induces Liver Steatosis through Deregulation of Genes Involved in Hepatic Lipid Metabolism
Tommasi, S., Yoon, J., & Nia, A. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041296 · Cited by 19
Cigarette smoking differentially regulates inflammatory responses in a mouse model of nonalcoholic steatohepatitis depending on exposure time point
Kim, J.-W., Zhou, Z., Yun, H., Park, S., Choi, S., Lee, S. H., Lim, C. W., Lee, K., & Kim, B. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110930 · Cited by 17
Association between Serum Cotinine Level and Prevalence of Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study from the Third National Health and Nutrition Examination Survey
Shen, H., Peng, J. L., Tayarachakul, S., & Liangpunsakul, S. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000213 · Cited by 14
Long-Term Changes in Hepatic Fibrosis following Hepatitis C Viral Clearance in Patients with and without HIV
Balmaceda, J. B., Aepfelbacher, J., Belliveau, O., Chaudhury, C. S., Chairez, C. L., McLaughlin, M. E., Silk, R., Gross, C., Kattakuzhy, S. M., Rosenthal, E. S., et al. (2018) · Antiviral Therapy · doi:10.3851/imp3327 · Cited by 12
The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States
Wijarnpreecha, K., Scribani, M., Kim, D., & Kim, W. R. (2019) · Liver International · doi:10.1111/liv.14058 · Cited by 10
National digestive disease specialists survey on cardiovascular risk management in non‐alcoholic fatty liver disease in spanish hospitals
Iruzubieta, P., Arias, M., Fortea, J. I., Cuadrado, A., Rivas, C., Rodríguez-Duque, J. C., García‐Ibarbia, C., Hernández, J. L., & Crespo, J. (2021) · Liver International · doi:10.1111/liv.14807 · Cited by 9
The interaction between current smoking and hemoglobin on the risk of advanced fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease
Enc, F. Y., Ulaşoğlu, C., Bakır, A., & Yilmaz, Y. N. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001536 · Cited by 8
Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
Wei, Z., Ren, Z., Hu, S., Gao, Y. L., Sun, R., Lv, S., Yang, G., Yu, Z., & Kan, Q. (2019) · Cancer Medicine · doi:10.1002/cam4.2777 · Cited by 4
Enzymatic Responses to Alcohol and Tobacco Nicotine-Derived Nitrosamine Ketone Exposures in Long Evans Rat Livers.
Yalcin, E. B., Tong, M., & de la Monte, S. M. (2016) · PubMed · Cited by 2

Research works printed but not linked: 1

Waziry, 2017, The effects of waterpipe tobacco smoking on health outcomes: an updated systematic review and meta-analysis, Int J Epidemiol, 46, 32

Sorted by citations

EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 522
Lifestyle interventions in nonalcoholic fatty liver disease
Younossi, Z. M., Zelber-Sagi, S., Henry, L., & Gerber, L. H. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00800-4 · Cited by 281
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207
Self-citation
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
Aguado, D. M., Calleja, J. L., Vilar‐Gómez, E., Iruzubieta, P., Rodríguez-Duque, J. C., Barrio, M. D., Puchades, L. G., Rivera‐Esteban, J., Perelló, C., Puente, Á., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.036 · Cited by 206
Self-citation

See all 191

Authors: Marti-Aguado, D., Clemente-Sanchez, A., & Bataller, R.
Affiliations: University of Pittsburgh Medical Center (US)
Corresponding author: Bataller, Ramon
ORCID: Marti-Aguado, David
Clemente-Sanchez, Ana
Bataller, Ramon
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2022-07
Volume: 77
Issue: 1
Pages: 191-205
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2022.01.016
OpenAlex: W4210795703
Cited by: 190
References: 147
Citations by year: 2026: 33 · 2025: 67 · 2024: 60 · 2023: 24 · 2022: 6
FWCI: 5.40
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (am, 349 d)
Locations: Journal of Hepatology (acceptedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism (1U01AA026264-01, 1U01AA026972-01, 1U01AA026978-01, RO1AA018873)
National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK117881-01)
Asociación Española para el Estudio del Hígado
Instituto de Salud Carlos III
Ministerio de Ciencia e Innovación
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords: cigarette smoking, chronic liver disease, hepatic steatosis, liver fibrosis, hepatocellular carcinoma, steatohepatitis, oxidative stress, oncogenic signaling, smoking cessation, liver transplantation, cardiovascular disease, extrahepatic cancer, fibrosis regression
MeSH terms: Cigarette Smoking, Cardiovascular Diseases, Fibrosis, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Risk Factors, Smoking

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cigarette smoking and liver diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks